ZA202100375B - Therapy of high-risk human papillomavirus infections - Google Patents

Therapy of high-risk human papillomavirus infections

Info

Publication number
ZA202100375B
ZA202100375B ZA2021/00375A ZA202100375A ZA202100375B ZA 202100375 B ZA202100375 B ZA 202100375B ZA 2021/00375 A ZA2021/00375 A ZA 2021/00375A ZA 202100375 A ZA202100375 A ZA 202100375A ZA 202100375 B ZA202100375 B ZA 202100375B
Authority
ZA
South Africa
Prior art keywords
acid
human papillomavirus
therapy
composition
risk human
Prior art date
Application number
ZA2021/00375A
Other languages
English (en)
Inventor
Norbert Fuchs
Original Assignee
Selo Medical Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Selo Medical Gmbh filed Critical Selo Medical Gmbh
Publication of ZA202100375B publication Critical patent/ZA202100375B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA2021/00375A 2018-08-28 2021-01-19 Therapy of high-risk human papillomavirus infections ZA202100375B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18191289.0A EP3616693A1 (en) 2018-08-28 2018-08-28 Therapy of high-risk human papillomavirus infections
PCT/EP2019/072926 WO2020043762A1 (en) 2018-08-28 2019-08-28 Therapy of high-risk human papillomavirus infections

Publications (1)

Publication Number Publication Date
ZA202100375B true ZA202100375B (en) 2024-08-28

Family

ID=63442535

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2021/00375A ZA202100375B (en) 2018-08-28 2021-01-19 Therapy of high-risk human papillomavirus infections

Country Status (25)

Country Link
US (2) US20210299163A1 (cg-RX-API-DMAC7.html)
EP (2) EP3616693A1 (cg-RX-API-DMAC7.html)
JP (1) JP7420791B2 (cg-RX-API-DMAC7.html)
CN (1) CN112584828A (cg-RX-API-DMAC7.html)
AR (1) AR116027A1 (cg-RX-API-DMAC7.html)
AU (1) AU2019332079B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021003360A2 (cg-RX-API-DMAC7.html)
CA (1) CA3107691C (cg-RX-API-DMAC7.html)
CL (1) CL2021000197A1 (cg-RX-API-DMAC7.html)
EA (1) EA202190441A1 (cg-RX-API-DMAC7.html)
ES (1) ES2958808T3 (cg-RX-API-DMAC7.html)
GE (2) GEP20227432B (cg-RX-API-DMAC7.html)
HR (1) HRP20231470T1 (cg-RX-API-DMAC7.html)
HU (1) HUE064691T2 (cg-RX-API-DMAC7.html)
IL (1) IL281080B2 (cg-RX-API-DMAC7.html)
MA (1) MA53482B1 (cg-RX-API-DMAC7.html)
MD (1) MD3843715T2 (cg-RX-API-DMAC7.html)
MX (1) MX2021002310A (cg-RX-API-DMAC7.html)
PL (1) PL3843715T3 (cg-RX-API-DMAC7.html)
RS (1) RS64916B1 (cg-RX-API-DMAC7.html)
SM (1) SMT202300340T1 (cg-RX-API-DMAC7.html)
TW (1) TWI827652B (cg-RX-API-DMAC7.html)
UA (1) UA127632C2 (cg-RX-API-DMAC7.html)
WO (1) WO2020043762A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202100375B (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3875083A1 (en) * 2020-03-03 2021-09-08 Selo Medical GmbH Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
CN113304251A (zh) * 2021-03-04 2021-08-27 南京北极光生物科技有限公司 一种组合物在抗人乳头瘤病毒中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2406377C (en) 2000-05-10 2010-07-06 Okopharm Forschungs-Und Entwicklungs-Gmbh Method for reducing the surface area of silicon dioxide
AT412758B (de) 2000-06-05 2005-07-25 Vis Vitalis Lizenz & Handels Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen
AT412448B (de) 2001-02-13 2005-03-25 Vis Vitalis Lizenz & Handels Verwendung von selenhältigen präparaten
AT412703B (de) * 2001-12-04 2005-06-27 Vis Vitalis Lizenz & Handels Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung
AT511159A1 (de) * 2011-02-16 2012-09-15 Selo Medical Gmbh Pharmazeutische zusammensetzungen enthaltend selenit- oder selenathältige verbindungen

Also Published As

Publication number Publication date
SMT202300340T1 (it) 2023-11-13
IL281080B1 (en) 2024-08-01
EP3843715C0 (en) 2023-09-13
US20250281524A1 (en) 2025-09-11
US20210299163A1 (en) 2021-09-30
JP7420791B2 (ja) 2024-01-23
JP2021536454A (ja) 2021-12-27
PL3843715T3 (pl) 2024-02-19
HUE064691T2 (hu) 2024-04-28
MA53482A (fr) 2021-07-07
IL281080A (en) 2021-04-29
EP3616693A1 (en) 2020-03-04
GEP20227432B (en) 2022-10-25
CN112584828A (zh) 2021-03-30
AU2019332079A1 (en) 2021-02-11
TW202023534A (zh) 2020-07-01
EA202190441A1 (ru) 2021-06-15
MX2021002310A (es) 2021-04-28
MA53482B1 (fr) 2023-11-30
RS64916B1 (sr) 2023-12-29
AU2019332079B2 (en) 2024-08-29
MD3843715T2 (ro) 2023-12-31
EP3843715A1 (en) 2021-07-07
AR116027A1 (es) 2021-03-25
TWI827652B (zh) 2024-01-01
WO2020043762A1 (en) 2020-03-05
HRP20231470T1 (hr) 2024-03-01
UA127632C2 (uk) 2023-11-08
IL281080B2 (en) 2024-12-01
CA3107691C (en) 2024-10-29
GEAP202215586A (en) 2022-06-27
CA3107691A1 (en) 2020-03-05
BR112021003360A2 (pt) 2021-05-11
ES2958808T3 (es) 2024-02-15
CL2021000197A1 (es) 2021-09-20
EP3843715B1 (en) 2023-09-13

Similar Documents

Publication Publication Date Title
M Tebit et al. Mucosal transmission of human immunodeficiency virus
WO2007121895A3 (en) Hpv-16-based papillomavirus vaccine
WO2002090382A3 (fr) Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications
JP2006512413A5 (cg-RX-API-DMAC7.html)
JP2016513703A5 (cg-RX-API-DMAC7.html)
EA202190441A1 (ru) Терапия папилломавирусных инфекций человека высокого риска
CA2510457A1 (en) Hpv-16 and -18 l1 vlp vaccine
PE20230349A1 (es) Vacunas para la papilomatosis respiratoria recurrente y metodos para usar estas
WO2019222768A3 (en) Aqueous hypohalous acid preparations for the inactivation of resistant infectious agents
CN101181636B (zh) 一种防治人乳头瘤病毒感染的复方疫苗组合物、复方疫苗阴道喷雾剂及其用途
JP2021525266A5 (cg-RX-API-DMAC7.html)
JP2021536454A5 (cg-RX-API-DMAC7.html)
Lee et al. A case of isolated bowenoid papulosis of the nipple
MX2022016148A (es) Formulaciones.
MY198473A (en) Glucono delta-lactone for treatment of vaginal fungal infections
MX2019013371A (es) Biomarcadores clinicos e inmunologicos para la regresion de la displasia de cuello uterino de grado elevado y eliminacion de infeccion por hpv16 y hpv18 luego de la inmunoterapia.
Tauber et al. Unresectable perineal cuniculatum carcinoma: partial remission using systemic isotretinoin and interferon-α2a therapy
MEHEDINȚU et al. A fixed herbal combination-A new approach in HPV cervical infection treatment
EA202190589A1 (ru) Способ комбинированной терапии дисплазии шейки матки, ассоциированной с вирусами папилломы человека
JP6663438B2 (ja) 癌および皮膚病変の治療
Pestrikova et al. Assessment of viral load in patients with HPV-associated cervicitis during the course of complex treatment
IL296146A (en) Preparations containing compounds containing selenite for use in the treatment of cervical cell abnormalities
JP2023516153A5 (cg-RX-API-DMAC7.html)
Heitmann et al. A Case of Erythema Multiforme
ZHENG et al. Correlation Between Cervical Cancer HPV Infection and Cervical Intraepithelial